post-op pain. pain
Conditions
Interventions
Intervention 1: intervention groups
group 1: receive either 30 ml of bupivacaine 0.5% plus 2-ml normal salin, 16-ml in each side ( n=18 )
group 2: 30 ml of bupivacaine 0.5% plus 2 ml sufentanil,
Treatment - Drugs
Placebo
intervention groups
group 1: receive either 30 ml of bupivacaine 0.5% plus 2-ml normal salin, 16-ml in each side ( n=18 )
group 2: 30 ml of bupivacaine 0.5% plus 2 ml sufentanil, 16 ml in each
Control group: 32 ml of 0.9% normal salin 16 ml in each side (n=18), at the end of surgical procedure
Sponsors
Tehran university of medical science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria; all candidates with laparascopic cholecystectomy; age between 20-65 years old; without any allergy to the drugs use in this study; addiction; without infection at the side of needle insertion; without contraandication for TAP block. Exclusion criteria: any patients with surgical complication; and in cases which operation last more than 3 hours; the cases were excluded from study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The first time of requesting opioid for releasing the pain from patient. Timepoint: 0, 0.5, 1 , 6, 12, 24 hours after surgery. Method of measurement: Whole amount of opioid usage with PCA pomp in PACU recorded by an expert physician. | — |
Secondary
| Measure | Time frame |
|---|---|
| Variation of the post-op pain. Timepoint: 0, 1, 3, 6, 12, 24 hours after surgery. Method of measurement: Recording the pain score with the protocol of VAS system by an expert phycision. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Movafegh
Anesthesiology Dep, Tehran University of Medical Sciences
Outcome results
None listed